Cure My Disease

Don't miss your cure!

 Log in / Sign up

New pill hopes to slow Parkinson's in early stages

NCT ID NCT06329141

Completed Disease control Sponsor: Glaceum Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 09, 2026 · Updated 2 times

Summary

This study tested a new drug called vutiglabridin in 99 people with early Parkinson's disease. Participants took either the drug or a placebo daily for 24 weeks. The goal was to see if the drug is safe and can help control symptoms like movement problems. The study is complete, but results are not yet reported.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSON DISEASE

Contacts and locations

Locations

  • Hallym University Medical Center

    Anyang-si, Gyeonggi-do, 14068, South Korea

  • Inje University Busan Paik Hospital

    Busan, 47392, South Korea

  • Inje University Sanggye Paik Hospital

    Seoul, 01757, South Korea

  • Korea University Guro Hospital

    Seoul, 08308, South Korea

  • KyungHee University Medical Center

    Seoul, 02447, South Korea

  • Samsung Medical Center

    Seoul, 06351, South Korea

  • Severance Hospital

    Seoul, 03722, South Korea

  • The Catholic University of Korea

    Seoul, 06591, South Korea

  • The Catholic University of Korea Uijeongbu St.Marys Hostpial

    Uijeongbu-si, Gyeonggi-do, 11765, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.